| Dennis Phillip Andrew | Chief Medical Officer | 8,209Ordinary Shares | — | Sell | |
|---|
| Dennis Phillip Andrew | Chief Medical Officer | 10,302Restricted Share Units | — | Exercise / conversion | |
|---|
| Dennis Phillip Andrew | Chief Medical Officer | 23,695Ordinary Shares | — | Exercise / conversion | |
|---|
| Cao Sean Wuxiong | Chief Bus. Development Officer | 107,978Ordinary Shares | — | Sell | |
|---|
| Cao Sean Wuxiong | Chief Bus. Development Officer | 147,553Restricted Share Units | — | Exercise / conversion | |
|---|
| Cao Sean Wuxiong | Chief Bus. Development Officer | 339,372Ordinary Shares | — | Exercise / conversion | |
|---|
| Xu Cong Claire | EVP, Clinical Development | 3,282Ordinary Shares | — | Sell | |
|---|
| Xu Cong Claire | EVP, Clinical Development | 4,079Restricted Share Units | — | Exercise / conversion | |
|---|
| Xu Cong Claire | EVP, Clinical Development | 9,382Ordinary Shares | — | Exercise / conversion | |
|---|
| Lenz Robert A. | Director | 7,486Restricted Share Units | — | Exercise / conversion | |
|---|
